Patent · US Active

Chimeric adenoviral vectors

US7879602B2 · kind B2 · utility

3Cited by
1References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 28, 2007
Grant dateFeb 1, 2011
Priority date
Expiry dateJul 6, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.